Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Case Discussion: Optimizing ART in Women of Childbearing Potential and Pregnancy (11 mins)
  • CME

Credits Available
Physicians: maximum of 1.25 AMA PRA Category 1 Credits
Pharmacists: 1.25 contact hours (0.125 CEUs)
Released: August 18, 2020 Expiration: August 17, 2021
Start Activity
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an education grant from
Merck Sharp & Dohme Corp.
Monica Gandhi, MD, MPH
Program Director
Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
Pedro Cahn, MD, PhD
Laura Waters, FRCP, MD

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Integrate newer ART agents into the care of people living with HIV
  • Appropriately evaluate and manage emerging adverse events associated with ART
  • Provide individualized care for key populations of patients living with HIV, such as women
  • Critically appraise the current and future role of emerging paradigms for ART

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Program Director

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Monica Gandhi, MD, MPH, has no relevant conflicts of interest to report.

Faculty

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD

Chief Operating Officer
Desmond Tutu HIV Foundation
Deputy Director
Desmond Tutu HIV Centre
Immediate Past President
International AIDS Society
Faculty of Health Sciences
University of Cape Town,
Cape Town, South Africa

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, has no relevant conflicts of interest to report.
Pedro Cahn, MD, PhD

Senior Consultant, Infectious Diseases
Hospital Juan Fernández
Director, Fundación Huesped
Professor of Infectious Diseases
Buenos Aires University Medical School
Buenos Aires, Argentina

Pedro Cahn, MD, PhD, has disclosed that he has received funds for research support and consulting fees from Merck and ViiV Healthcare and fees for non-CME/CE services from Gilead Sciences, Merck, and ViiV Healthcare
Laura Waters, FRCP, MD

Consultant Physician, HIV/GU Medicine
Mortimer Market Centre
CNWL NHS Trust
London, United Kingdom

Laura Waters, FRCP, MD, has disclosed that she has received consulting fees from Cipla, Gilead Sciences, Janssen, MSD, Mylan, and ViiV Healthcare.

Staff

Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer M. Blanchette, PhD, has no relevant conflicts of interest to report.
Edward King, MA

Executive Vice President

Edward King, MA, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.
Tiffany Hensley-McBain, PhD

Associate Scientific Director

Tiffany Hensley-McBain, PhD, has no relevant conflicts of interest to report.
Megan K. Murphy, PhD

Scientific Director

Megan K. Murphy, PhD, has no relevant conflicts of interest to report.
Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

The program is intended for physicians, pharmacists, and other healthcare professionals who provide care for people at risk of, or living with, HIV

Goal

The goal of this activity is to improve the knowledge and competence of learners in optimizing and individualizing HIV treatment for each patient, including the appropriate integration of new and emerging ART strategies.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-20-087-H02-P.

Type of Activity: Knowledge

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 18, 2020, through August 17, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Case Discussion: Optimizing ART in Women of Childbearing Potential and Pregnancy (11 mins)
  • CME

Faculty discuss considerations for ART management in a virologically suppressed woman trying to conceive.
Monica Gandhi, MD, MPH
Program Director
Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
Pedro Cahn, MD, PhD
Laura Waters, FRCP, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits
Pharmacists: 1.25 contact hours (0.125 CEUs)
Released: August 18, 2020 Expiration: August 17, 2021

This program is divided into short segments that you can review from the activity landing page.

Related Content

CCO commentary by Jennifer Cocohoba, PharmD, on how to avoid polypharmacy in aging patients with HIV

Jennifer Cocohoba Headshot Jennifer Cocohoba, PharmD Released: October 12, 2020

CCO slides on ending the HIV epidemic in the United States via expanded testing, enhanced linkage to care, and rapid response to potential outbreaks

Lisa K. Fitzpatrick, MD, MPH, MPA David Malebranche, MD, MPH Released: October 7, 2020

Downloadable PDF resource from CCO on HCV and HIV screening essentials and HIV PrEP basics for addiction medicine specialists

Andrew Seaman, MD Released: October 2, 2020

Expert-authored CCO slides on the impact of HIV infection on COVID-19 risk and disease severity and the impact of COVID-19 on access to HIV care

W. David Hardy, MD
Program Director
Monica Gandhi, MD, MPH
Released: September 25, 2020

Video Chapters


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an education grant from
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue